Fortis Healthcare Limited (FORTIS) — Announcement | 20 July 2026

· NSE Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Fortis names Vijender Singh MD & CEO of Agilus Diagnostics
💡 Investor Takeaway
This leadership change may strengthen Agilus Diagnostics' execution and growth prospects.

Fortis Healthcare announced the appointment of Vijender Singh as Managing Director and CEO of its subsidiary Agilus Diagnostics, effective July 20, 2026, following Dr. Anand K's resignation after six years with the company.

📄 View Original Announcement (PDF)

About Fortis Healthcare Limited (FORTIS)

Healthcare · Healthcare Services · Listed on NSE

Market Cap: ₹72,751.54 Cr P/E: 94.6

View full FORTIS stock details →

📡 Get AI alerts when FORTIS files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track FORTIS — Free

📊 More FORTIS filings

See all FORTIS filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when FORTIS files new disclosures

Track FORTIS filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track FORTIS — Free

Free account · 2 AI queries/day